Eli Lilly and Company Research Report - FY2023 Q2

Search

FY2023 Q2: Mounjaro Powers 22% Core Revenue Growth; Full-Year Guidance Raised by $2.2 Billion

Sign in required

Sign in or create an account to continue to this document.

Sign in Create account
Pic
dbot